Beobachten
- Pressemitteilung BoxID 509838
The Microplate Reader Company Presents its Newest HTS Technology at European Laboratory Automation (ELA) 2012
(PresseBox) (Ortenberg, )
In Hamburg, Germany on May 30-31st BMG LABTECH, the Microplate Reader Company, will showcase its newest technology at ELA 2012. Stop by Booth #120 to see unique and proprietary microplate reader technology that separates BMG LABTECH from the rest. BMG LABTECH features not found on any other instrument, include: ultra-fast, full spectrum (220-1000 nm) absorbance analysis for chemical or biological samples; laser-based, light-scattering nephelometery for measuring compound solubility; Atmospheric Control Unit (ACU) for optimizing cell-based assay experiments or for inducing disease states such as hypoxia; and Direct Optic Bottom reading for unmatched signal-to-noise ratios in all fluorescent protein assays such as GFP, YFP and mCherry.
BMG LABTECH will also highlight their microplate readers in several application posters. One poster, presented in conjunction with Pharma Diagnostics, will show how the SoPRanoTM label-free technology is easily executed on a BMG LABTECH spectrometer-based microplate reader. When proteins bind to the SoPRanoTM Gold-Nano Rods, there is a shift in the ODmax. This ODmax shift is easily monitored with a BMG LABTECH spectrometer-based instrument, which can capture a full spectrum in less than one second per well. This allows protein-protein interactions to be readily monitored with this system. Another poster, in conjunction with BellBrook Laboratories, describes the generic Transcreener® FP assay platform that can be used to measure a diverse set of enzymes in an HTS format, including Methyltransferase, Acetyltransferase, Kinases, ATPases, and GTPases. These robust and highly reproducible assays were performed on the PHERAstar Plus HTS instrument using Simultaneous Dual Emission (SDE) detection. Simultaneous Dual Emission Detection substantially reduces plate read times and it corrects for any signal variations due to differences in well volumes, concentrations, or fluctuations in excitation energy.
Please visit BMG LABTECH at Booth #120 at ELA 2012 or our website www.bmglabtech.com to learn more about the future of microplate reader technology today.
BMG LABTECH will also highlight their microplate readers in several application posters. One poster, presented in conjunction with Pharma Diagnostics, will show how the SoPRanoTM label-free technology is easily executed on a BMG LABTECH spectrometer-based microplate reader. When proteins bind to the SoPRanoTM Gold-Nano Rods, there is a shift in the ODmax. This ODmax shift is easily monitored with a BMG LABTECH spectrometer-based instrument, which can capture a full spectrum in less than one second per well. This allows protein-protein interactions to be readily monitored with this system. Another poster, in conjunction with BellBrook Laboratories, describes the generic Transcreener® FP assay platform that can be used to measure a diverse set of enzymes in an HTS format, including Methyltransferase, Acetyltransferase, Kinases, ATPases, and GTPases. These robust and highly reproducible assays were performed on the PHERAstar Plus HTS instrument using Simultaneous Dual Emission (SDE) detection. Simultaneous Dual Emission Detection substantially reduces plate read times and it corrects for any signal variations due to differences in well volumes, concentrations, or fluctuations in excitation energy.
Please visit BMG LABTECH at Booth #120 at ELA 2012 or our website www.bmglabtech.com to learn more about the future of microplate reader technology today.
Diese Pressemitteilungen könnten Sie auch interessieren
|
Fachtagung 2013 des Gissel Instituts: Aktuelle Themen rund um die Fleischverarbeitung stehen im Blickpunkt
, Biotechnik, Gissel Institut für Bakteriologie und Hygiene
Kaum eine Veranstaltung dürfte geeigneter sein, sich in Sachen Fleisch und Fleischwaren auf den neuesten Stand zu bringen, als die regelmäßige Fachtagung des renommierten...
|
Reading und Imaging vereint im neuen, revolutionären Cytation™3 von BioTek
, Biotechnik, BIOTEK Instruments GmbH
BioTek kündigt stolz die erste Kombination aus Multi-Detektions-Reader mit Hybrid-Technologie und Imaging-System an - den Cytation™3 Multi-Detektions-Reader für...
|
New Roche Award for Antibody-based Cancer Therapy Research
, Biotechnik, Roche Diagnostics GmbH
In a newly created award, pRED's Discovery Oncology unit of Roche (SIX: RO, ROG; OTCQX: RHHBY) in Penzberg, Germany invites European researchers to submit abstracts...
